The Leukaemia Foundation funds vital research into the causes, epidemiology, diagnosis and treatment, psychosocial impact and ultimately cures for leukaemias, lymphomas, myeloma and related blood disorders.
The Leukaemia Foundation Research Unit at the Queensland Institute of Medical Research was established to find cures for blood cancers and related disorders and deliver the benefits to patients as quickly as possible.
The Australasian Leukaemia and Lymphoma Tissue Bank gives researchers access to accumulated tissue samples of blood disorders and enables research groups to rapidly conduct larger scale studies.
The Australian Blood Cancer Registry is being developed to collect detailed and accurate information on blood cancers. The information will be used to improve the capacity of clinicians, patients and governments to make informed and timely decisions on the management of blood cancers.
Since 2009, the Leukaemia Foundation has partnered with Cancer Australia to advance research into blood cancers. We are currently partnering in funding research to lymphoma and myelodysplastic syndromes. In 2011 we are calling for applications for research into myeloma.
Clinical trials seek to deliver better treatments and cures of leukaemias, lymphomas, myeloma or related disorders. These trials may provide vital information and give people access to new therapies not yet funded by governments.